What Is Rcc Renal Cell Carcinoma Explained?

Renal cell carcinoma, often shortened to RCC, is the most common type of kidney cancer in adults. It starts in the tiny tubes of the kidney called tubules, which normally filter waste from the blood to make urine. When cells in these tubules grow out of control, they form a tumor. RCC accounts for about 9 out of 10 kidney cancer diagnoses, making it the form most people mean when they say “kidney cancer.”

How Does Renal Cell Carcinoma Start and Grow?

Your kidneys sit near the middle of your back, one on each side of your spine. Each one is roughly the size of a fist. Inside, millions of microscopic tubules work as filters. Renal cell carcinoma begins when the DNA inside one of these tubule cells changes.

That damaged cell does not die when it should. Instead, it keeps dividing. Over time, those extra cells form a mass. Some RCC tumors grow slowly for years without causing any trouble. Others grow quickly and can spread beyond the kidney.

The disease gets its name from where it starts. “Renal” means kidney. “Cell” refers to the cell type. “Carcinoma” means cancer that begins in the lining of an organ. So the name tells you exactly what and where it is.

What Are the Main Types of Renal Cell Carcinoma?

Not all RCC is the same. Doctors look at the cells under a microscope to figure out which subtype you have. This matters because different types behave differently and respond to different treatments.

Clear cell RCC is the most common, making up about 75% of cases. The cells look pale or clear under a microscope because they are full of fat and sugar. This type is most likely to spread to other organs if not caught early.

Papillary RCC is the second most common, accounting for about 15% of cases. The cells form finger-like projections. It often grows more slowly but can still spread.

Chromophobe RCC is less common, around 5% of cases. The cells are larger and pale pink. This type generally grows slowly and has a better outlook than clear cell.

There are also rarer subtypes like collecting duct carcinoma and medullary carcinoma. These are much less common and can be more aggressive. Your doctor will need a biopsy or a surgical sample to determine which subtype you have.

Who Gets Renal Cell Carcinoma and Why?

RCC is more common in men than women, with about twice as many men diagnosed. It usually appears after age 45, with most cases found between ages 60 and 70. But younger people can get it too, especially those with certain inherited conditions.

Smoking is one of the strongest risk factors. People who smoke have a higher chance of developing RCC, and the risk goes up with the number of cigarettes smoked. Quitting lowers the risk over time.

Obesity also increases risk. Excess body weight changes hormone levels and causes chronic inflammation, both of which may help cancer cells grow.

High blood pressure is another established risk factor. Some research suggests the risk comes from the high blood pressure itself, not just the medications used to treat it.

Certain inherited conditions raise the risk significantly. Von Hippel-Lindau disease, hereditary papillary renal cell carcinoma, and Birt-Hogg-Dubé syndrome all increase the chance of developing RCC. These are rare, but anyone with a strong family history of kidney cancer should talk to a doctor about screening.

Long-term dialysis for kidney failure also raises the risk. So does exposure to certain chemicals, including asbestos and cadmium, though these are less common causes.

What Symptoms Should You Watch For?

Early RCC often causes no symptoms at all. Many tumors are found by accident when a person gets an imaging scan for an unrelated reason, like a CT scan for back pain or an ultrasound for gallstones. This is one reason the disease is sometimes called a “silent” cancer.

When symptoms do appear, the classic trio includes blood in the urine, pain in the side or lower back, and a lump you can feel. But this full trio is rare and usually means the cancer is advanced.

Blood in the urine is the most common symptom. It may be visible to the eye, turning the urine pink, red, or cola-colored. Or it may only show up on a urine test. Either way, it deserves a medical workup.

Other possible symptoms include:

• Unexplained weight loss
• Ongoing fatigue
• Fever that is not from an infection
• Night sweats
• Loss of appetite
• Anemia or low red blood cell count

RCC can also cause paraneoplastic syndromes. These are symptoms caused by hormones the tumor secretes, not by the tumor itself. They can include high calcium levels, high blood pressure, or an elevated red blood cell count. Sometimes these symptoms appear before the tumor is even found.

How Is Renal Cell Carcinoma Diagnosed?

Imaging is usually the first step. A CT scan with contrast dye is the standard test. It can show a kidney mass and whether it has grown into nearby veins or spread to lymph nodes. An MRI may be used if contrast dye cannot be given safely, such as in people with poor kidney function.

An ultrasound is often used to follow up on a mass found incidentally. It can tell whether a mass is solid or filled with fluid. Solid masses are more concerning for cancer, though some fluid-filled cysts also need monitoring.

A biopsy is not always needed before surgery. If imaging clearly shows a tumor that should be removed, many surgeons go straight to surgery. But a biopsy may be done when the diagnosis is unclear, when the tumor is small and active surveillance is being considered, or when the patient is not a good surgical candidate.

If cancer is confirmed, doctors stage it. Staging describes how far the cancer has spread. Stage 1 tumors are small and confined to the kidney. Stage 2 tumors are larger but still inside the kidney. Stage 3 means the tumor has grown into major veins or nearby lymph nodes. Stage 4 means it has spread to distant organs like the lungs, bones, or brain.

About two-thirds of RCC cases are found when the cancer is still localized to the kidney. This is good news because localized disease is much more treatable.

What Are the Treatment Options?

Treatment depends on the stage, the subtype, the tumor’s grade, and your overall health. No single approach works for everyone.

Surgery is the primary treatment for localized RCC. A radical nephrectomy removes the entire kidney along with the tumor. A partial nephrectomy removes only the tumor and leaves the healthy part of the kidney. Partial nephrectomy is preferred when possible because preserving kidney function lowers the risk of long-term kidney disease.

For small tumors under 4 centimeters, active surveillance is sometimes an option. This means monitoring the tumor with regular scans instead of treating it right away. Some small tumors grow very slowly or not at all. Active surveillance avoids the risks of surgery for people who may never need it.

Ablation therapies use extreme cold or heat to destroy the tumor without removing it. Cryoablation freezes the tumor. Radiofrequency ablation heats it. These are less invasive than surgery but are typically reserved for small tumors in people who cannot tolerate an operation.

For advanced or metastatic RCC, systemic treatments are used. Targeted therapies block specific proteins that help cancer cells grow. Drugs like sunitinib, pazopanib, and axitinib target blood vessel formation, starving the tumor of its blood supply. Immunotherapy helps your own immune system recognize and attack the cancer. Drugs like nivolumab and pembrolizumab are checkpoint inhibitors that take the brakes off immune cells.

These treatments have changed the outlook for advanced RCC dramatically over the past decade. Many people with stage 4 disease now live years longer than they would have with older treatments. But they are not cures for most people, and they come with side effects like fatigue, skin reactions, and immune-related inflammation.

Radiation therapy plays a limited role in RCC. This cancer type is generally resistant to radiation. It may be used to relieve pain from bone metastases or to treat brain metastases, but it is not a primary treatment for the kidney tumor itself.

What Is the Outlook for Someone With RCC?

The outlook depends heavily on the stage at diagnosis. For localized RCC that is removed completely with surgery, the five-year survival rate is high. Many people are cured by surgery alone.

For cancer that has spread to distant organs, the prognosis is more serious. But the introduction of targeted therapies and immunotherapies has improved survival significantly. Some people with metastatic disease respond well to treatment and live for many years.

Several factors affect prognosis beyond stage. The grade of the tumor, which describes how abnormal the cells look, matters. Lower-grade tumors grow more slowly. The subtype also plays a role. Chromophobe RCC generally has a better outlook than clear cell or papillary types.

Your overall health and performance status matter too. People who are otherwise healthy tend to tolerate treatment better and have better outcomes.

After treatment, regular follow-up is essential. RCC can recur, sometimes years after the original diagnosis. Follow-up typically involves periodic imaging scans and blood tests. The schedule depends on your risk of recurrence.

Can Renal Cell Carcinoma Be Prevented?

There is no guaranteed way to prevent RCC. But you can lower your risk by addressing the modifiable factors.

Quitting smoking is the single most impactful prevention step. The risk of RCC drops in former smokers compared to current smokers.

Maintaining a healthy weight also helps. Obesity is linked to higher RCC risk, so weight loss in overweight individuals may reduce that risk.

Controlling blood pressure is another important step. If you have high blood pressure, work with your doctor to manage it through lifestyle changes and medication if needed.

A diet rich in fruits and vegetables has been associated with lower kidney cancer risk in some studies, though the evidence is not as strong as for smoking and obesity. Staying hydrated and limiting alcohol are reasonable general health measures, but they have not been proven to specifically prevent RCC.